• DOI:10.1007/s40259-016-0199-9
Corpus ID: 34367910

Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence

@article{Jacobs2016MonoclonalAA,
  title={Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence},
  author={I. Jacobs and Danielle Petersel and L. Shane and Chee-Keng Ng and C. Kirchhoff and G. Finch and S. Lula},
  journal={Biodrugs},
  year={2016},
  volume={30},
  pages={489 - 523}
}

I. Jacobs, Danielle Petersel, +4 authors S. Lula

Published 2016

Medicine

Biodrugs

BackgroundDespite regulatory efforts to formalize guidance policies on biosimilars, there remains a need to educate healthcare stakeholders on the acknowledged definition of biosimilarity and the data that underpin it. [...] Key MethodMethodsMEDLINE, Embase, and ISI Web of Science were searched to September 2015. Conference proceedings (n = 17) were searched 2012 to July 2015. Included studies were categorized by originator, study type, and indication.Expand Abstract

View on Springer

link.springer.com

Save to Library

Create Alert

Cite

Launch Research Feed